We’re excited to join @UCBerkeley in announcing a new research collaboration with the university’s @MTI_UCB to help accelerate the discovery and development of innovative therapies for rare genetic conditions.

The initial phase of the collaboration will support specific joint research projects between BioMarin scientists and UC Berkeley researchers. The partnership will bring together the university’s strengths in fundamental disease biology, novel therapeutic technologies and next-generation drug discovery with BioMarin’s deep expertise in translating science into transformational medicines.

Read more: http://ms.spr.ly/6015QnuJ3